AB 2276

  • California Assembly Bill
  • 2019-2020 Regular Session
  • Introduced in Assembly
  • Passed Assembly Jun 10, 2020
  • Senate
  • Governor

Medi-Cal: Blood lead screening tests.

Abstract

Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law authorizes the department to enter contracts with managed care plans to provide Medi-Cal services, and imposes requirements on the Medi-Cal managed care plans, including network adequacy standards. Under existing law, Medi-Cal covers early and periodic screening, diagnostic, and treatment for individuals under 21 years of age, consistent with federal law. This bill would require the department to ensure that a Medi-Cal beneficiary who is a child receives blood lead screening tests at specified ages consistent with state regulatory standards, and would require a contract between the department and a Medi-Cal managed care plan to ensure that the Medi-Cal managed care plan and its contracting health care providers who are responsible for performing a periodic health assessment of a child meet specified standard of care requirements relating to blood lead testing. The bill would require the department to report its progress toward blood lead screening tests for Medi-Cal beneficiaries who are children, as specified, annually on its internet website. The bill would require each Medi-Cal managed care plan to establish a monitoring system related to blood lead screening tests, to require its contracting health care providers who are responsible for performing a periodic health assessment of a child to test each child pursuant to specified standards of care for lead testing, to inform a child's parent, parents, guardian, or other person charged with their support and maintenance with specified information, including the risks and effects of lead exposure, and to notify a child's health care provider when that child has missed a required blood lead screening test. The bill would provide that it is the goal of the state that children at risk of lead exposure receive blood lead screening tests.

Bill Sponsors (6)

Votes


Actions


Jul 01, 2020

Senate

Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

Jun 11, 2020

Senate

In Senate. Read first time. To Com. on RLS. for assignment.

Jun 10, 2020

Assembly

Read third time. Passed. Ordered to the Senate. (Ayes 78. Noes 0.)

Jun 04, 2020

Assembly

Read second time. Ordered to third reading.

Assembly

Coauthors revised.

Jun 03, 2020

Assembly

From committee: Do pass. (Ayes 18. Noes 0.) (June 3).

Jun 02, 2020

Assembly

In committee: Set, first hearing. Referred to APPR. suspense file.

  • Referral-Committee
APPR APPR. suspense file.

May 19, 2020

Assembly

From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (May 18). Re-referred to Com. on APPR.

  • Committee-Passage-Favorable
  • Committee-Passage
  • Referral-Committee
Com. on APPR.

May 13, 2020

Assembly

Re-referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

May 12, 2020

Assembly

From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.

Feb 24, 2020

Assembly

Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

Feb 15, 2020

Assembly

From printer. May be heard in committee March 16.

Feb 14, 2020

Assembly

Read first time. To print.

Bill Text

Bill Text Versions Format
AB2276 HTML
02/14/20 - Introduced PDF
05/12/20 - Amended Assembly PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated nightly from the official website of the California State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.